Adjuvanted Modified Bacterial Antigens for Single-Dose Vaccines

Area of Science:

• Vaccinology
• Immunology
• Biochemistry

Background:

• Alum is a widely used vaccine adjuvant known for its safety and affordability.
• However, alum's complex mechanism and antigen-dependent immune responses can limit vaccine efficacy.
• Antigen desorption from alum can reduce bioavailability and immune stimulation.

Purpose of the Study:

• To enhance antigen binding to alum using phosphoserine modification.
• To improve antigen bioavailability and prolong retention at injection sites.
• To evaluate the immunogenicity of modified antigens for potential single-dose vaccine development.

Main Methods:

• Bacterial proteins and glycoconjugates were modified with phosphoserines.
• Antigen desorption from alum was assessed using competitive ELISA assays.
• In vivo optical imaging in mice was used to track antigen retention.
• Immune responses in mice were measured after single-dose vaccination.

Main Results:

• Phosphoserine modification significantly slowed antigen desorption from alum.
• Modified antigens showed prolonged retention at injection sites in mice.
• A single dose of modified antigens elicited stronger immune responses compared to unmodified antigens.
• Enhanced binding to alum was confirmed through ligand-exchange reactions.

Conclusions:

• Phosphoserine modification is a promising strategy to improve alum-adjuvanted vaccines.
• Enhanced antigen binding to alum can lead to potent single-dose vaccine candidates.
• This approach offers potential for novel carrier proteins and improved bacterial antigen-based vaccines.